Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids

Table 2 Patients’ characteristics

n		120
Age	Years	67 (11)
Diabetes duration	Years	16 (9)
Male: female	%	63: 37
Smoking^§		42-45-13
Body mass index	kg.m^-2	30.2 (5.6)
Waist circumference	cm	106 (15)
Metabolic syndrome	%	92
Hypertension	%	89
Anti-dyslipidemic drug(s)	%	92
Statin-fibrate-ezetimibe	%	81-38-12
HbA_1c	%	7.79 (1.32)
HbA_1c	mmol.mol^-1	62 (10)
Glomerular filtration rate	mL.min^-1 1.73 m²	73 (27)
Albuminuria	μg.mg creatinine^-1	90 (240)
Atherogenic dyslipidemia	%	58
Total cholesterol	mg.dL^-1	172 (34)
Non-HDL-C	mg.dL^-1	127 (33)
LDL-C	mg.dL^-1	91 (26)
TRL-C	mg.dL^-1	36 (20)
TG	mg.dL^-1	197 (101)
log[TG]	mg.dL^-1	2.23 (0.20)
apoB₁₀₀	mg.dL^-1	89 (21)
apoA-I	mg.dL^-1	145 (25)
HDL-C	mg.dL^-1	44 (12)
log[TG]/HDL-C		0.057 (0.024)
TRL-C/apoA-I		0.28 (0.20)
Macroangiopathy	%	33
Coronary artery disease	%	23
Peripheral artery disease	%	11
Transient ischemic attack/stroke	%	7

Results are expressed as means (1 SD) or proportions, with nonfasting lipids and lipoproteins values representing the means of Day 1 and Day 2. Apo apolipoprotein, C cholesterol, HbA_1c glycated haemoglobin, HDL high-density lipoprotein, LDL low-density lipoprotein, TG trigylycerides, TRL TG-rich lipoprotein; ^§never-former-current.

ISSN: 1475-2840